title: Comparative clinical studies of nitazoxanide, albendazole and praziquantel in the treatment of ascariasis, trichuriasis and hymenolepiasis in children from Peru.
abstract: Three randomized clinical studies were conducted in 2000 to evaluate the efficacy of nitazoxanide paediatric suspension compared to albendazole in the treatment of ascariasis and trichuriasis and praziquantel in the treatment of hymenolepiasis in children from Cajamarca, Peru. Nitazoxanide was administered at a dose of 100 mg (age 1-3 years) or 200 mg (age 4-11 years) twice daily for 3 days, albendazole as a 400-mg single dose and praziquantel as a 25-mg/kg single dose. Post-treatment parasitological examinations were carried out on 3 faecal samples, each collected on a different day between 21 and 30 days following initiation of treatment. Nitazoxanide cured 89% (25/28), 89% (16/18) and 82% (32/39) of the cases of ascariasis, trichuriasis and hymenolepiasis respectively compared with 91% (32/35), 58% (11/19) and 96% (47/49) for the comparator drugs. Each of the drugs produced egg reduction rates in excess of 98%. There were no significant adverse events or abnormalities in haematology or clinical chemistry values or urinalysis.
authors.affiliation: Cajamarca General Hospital, Cajamarca, Peru.
authors.forename: Jave Ortiz
authors.initials: JO
authors.lastname: Juan
authors.forename: Nicholas
authors.initials: N
authors.lastname: Lopez Chegne
authors.forename: Gilles
authors.initials: G
authors.lastname: Gargala
authors.forename: Loic
authors.initials: L
authors.lastname: Favennec
mesh_terms: D015766:Albendazole / Q000008:administration & dosage* / Q000009:adverse effects; D000818:Animals; D000871:Anthelmintics / Q000008:administration & dosage* / Q000009:adverse effects; D000923:Anticestodal Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001196:Ascariasis / Q000188:drug therapy; D001200:Ascaris / Q000302:isolation & purification; D002648:Child; D002675:Child, Preschool; D005260:Female; D006373:Helminthiasis / Q000188:drug therapy*; D006801:Humans; D006925:Hymenolepiasis / Q000188:drug therapy; D006926:Hymenolepis / Q000302:isolation & purification; D008297:Male; D009574:Nitro Compounds; D010270:Parasite Egg Count; D010568:Peru; D011223:Praziquantel / Q000008:administration & dosage* / Q000009:adverse effects; D013844:Thiazoles / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome; D014257:Trichuriasis / Q000188:drug therapy; D014258:Trichuris / Q000302:isolation & purification
chemical_list: D000871:Anthelmintics; D000923:Anticestodal Agents; D009574:Nitro Compounds; D013844:Thiazoles; D011223:Praziquantel; D015766:Albendazole; C041747:nitazoxanide